CN106572979B - 递送体系 - Google Patents

递送体系 Download PDF

Info

Publication number
CN106572979B
CN106572979B CN201580041052.6A CN201580041052A CN106572979B CN 106572979 B CN106572979 B CN 106572979B CN 201580041052 A CN201580041052 A CN 201580041052A CN 106572979 B CN106572979 B CN 106572979B
Authority
CN
China
Prior art keywords
delivery vehicle
polymer
lipid
digestible
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201580041052.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN106572979A (zh
Inventor
T·J·伍斯特
L·多纳托-卡博尔
A·萨卡
S·阿奎斯塔帕切
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe des Produits Nestle SA
Publication of CN106572979A publication Critical patent/CN106572979A/zh
Application granted granted Critical
Publication of CN106572979B publication Critical patent/CN106572979B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201580041052.6A 2014-08-07 2015-07-27 递送体系 Expired - Fee Related CN106572979B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180139.9 2014-08-07
EP14180139 2014-08-07
PCT/EP2015/067123 WO2016020217A1 (en) 2014-08-07 2015-07-27 A delivery system

Publications (2)

Publication Number Publication Date
CN106572979A CN106572979A (zh) 2017-04-19
CN106572979B true CN106572979B (zh) 2021-03-12

Family

ID=51302903

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580041052.6A Expired - Fee Related CN106572979B (zh) 2014-08-07 2015-07-27 递送体系

Country Status (5)

Country Link
US (2) US10052287B2 (cg-RX-API-DMAC7.html)
EP (1) EP3177274A1 (cg-RX-API-DMAC7.html)
JP (1) JP6660372B2 (cg-RX-API-DMAC7.html)
CN (1) CN106572979B (cg-RX-API-DMAC7.html)
WO (1) WO2016020217A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558072B1 (en) 2010-04-15 2018-09-26 The Washington University Prodrug compositions, prodrug nanoparticles, and methods of use thereof
CN107019797B (zh) * 2016-01-30 2020-07-03 天津赫莱恩特生物科技有限公司 一种提高球虫卵囊穿透细胞能力的组合物及其制备方法
FR3054104B1 (fr) 2016-07-19 2018-08-31 Galewpet Support pour l’absorption orale d’une substance active par des animaux, son procede de preparation et ses utilisations
WO2019066442A2 (ko) * 2017-09-27 2019-04-04 한양대학교 산학협력단 제2형 당뇨병 치료를 위한 락토페린 기반의 유전자 전달체
KR102144380B1 (ko) 2017-09-27 2020-08-13 한양대학교 산학협력단 제2형 당뇨병 치료를 위한 락토페린 기반의 유전자 전달체
JP7004968B2 (ja) * 2017-10-06 2022-01-21 青葉化成株式会社 食用の徐放性機能材の製造方法
KR102790073B1 (ko) 2017-11-03 2025-04-04 디에스엠 아이피 어셋츠 비.브이. 신규한 전달 체계
GB2571749A (en) * 2018-03-07 2019-09-11 Anabio Tech Limited A method inducing satiety in a mammal
WO2019170840A1 (en) 2018-03-07 2019-09-12 Anabio Technologies Ltd. A composition for type ii diabetics and for use in providing sustained energy release over time
CN110353271B (zh) * 2019-06-13 2022-07-22 陕西科技大学 一种抑制食道反流的特殊医学食品增稠组件及其制备方法
FR3102913B1 (fr) * 2019-11-07 2024-08-02 Huddle Corp Aliment ou complément alimentaire pour animaux d’élevage
US20220225650A1 (en) 2021-01-21 2022-07-21 Tropicana Products, Inc. Materials and Methods for Inhibiting Material Mixing in a Material Processing System
CN113368130B (zh) * 2021-06-25 2023-02-28 陕西科技大学 一种纤维状载铁复合物及其制备方法
US11590071B2 (en) 2021-07-06 2023-02-28 King Abdulaziz University Injectable drug delivery implant composition and method of use thereof
CN116999404B (zh) * 2023-06-21 2025-11-21 西南大学 一种分隔化多腔室铁蛋白递送体系的制备方法与应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010004256A1 (en) * 2008-06-17 2010-01-14 E-Therapeutics Plc Controlled release treatment of depression
CN101641087A (zh) * 2007-01-10 2010-02-03 加拿大海洋营养食品有限公司 素食的微胶囊
CN101790323A (zh) * 2007-08-28 2010-07-28 百事可乐公司 包囊亲脂性营养素的递送和受控释放
WO2014078912A1 (en) * 2012-11-26 2014-05-30 Progel Pty Ltd Coating composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115733A (ja) * 1984-06-30 1986-01-23 Miyoshi Oil & Fat Co Ltd マイクロカプセルの製造方法
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
BRPI0315977B8 (pt) * 2002-11-04 2021-05-25 Dsm Nutritional Products Ag microcápsulas possuindo múltiplas cascas e método para preparação destas
CA2510249A1 (en) * 2002-12-18 2004-07-01 Unilever Plc Complex coacervate encapsulate comprising lipophilic core
JP2006528883A (ja) * 2003-05-28 2006-12-28 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹感増強性食品
WO2007008384A2 (en) * 2005-07-07 2007-01-18 Ocean Nutrition Canada Ltd. Food articles with delivery devices and methods for the preparation thereof
US9332774B2 (en) * 2007-06-27 2016-05-10 Bunge Oils, Inc. Microencapsulated oil product and method of making same
US20100272762A1 (en) * 2009-04-22 2010-10-28 Dr. Suwelack Skin & Health Care Ag Freeze-Dried Coated Molded Article
US20110150995A1 (en) 2009-12-22 2011-06-23 Hemant Narahar Joshi Solid Dosage Forms of Essential Oils
EP2625966A1 (en) * 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof
CN103301091B (zh) * 2012-03-12 2014-12-03 昆明制药集团股份有限公司 一种天麻素两次脉冲释药制剂
CL2012002056A1 (es) * 2012-07-24 2014-01-24 Map Chile SpA Proteina animal micrencapsulada para consumo humano que comprende particulas proteicas, y una matriz de gelatina de origen animal; y particula de proteina animal microencapsulada para consumo humano.
US10075858B2 (en) * 2012-09-20 2018-09-11 Telefonaktiebolaget L M Ericsson (Publ) Weighted RSRP measurement

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101641087A (zh) * 2007-01-10 2010-02-03 加拿大海洋营养食品有限公司 素食的微胶囊
CN101790323A (zh) * 2007-08-28 2010-07-28 百事可乐公司 包囊亲脂性营养素的递送和受控释放
WO2010004256A1 (en) * 2008-06-17 2010-01-14 E-Therapeutics Plc Controlled release treatment of depression
WO2014078912A1 (en) * 2012-11-26 2014-05-30 Progel Pty Ltd Coating composition

Also Published As

Publication number Publication date
US20180325827A1 (en) 2018-11-15
WO2016020217A1 (en) 2016-02-11
CN106572979A (zh) 2017-04-19
EP3177274A1 (en) 2017-06-14
US10646450B2 (en) 2020-05-12
US20170231917A1 (en) 2017-08-17
US10052287B2 (en) 2018-08-21
JP2017532291A (ja) 2017-11-02
JP6660372B2 (ja) 2020-03-11

Similar Documents

Publication Publication Date Title
US10646450B2 (en) Delivery system comprising a core and a digestible polymer shell
Liu et al. Preparation, formation mechanism and in vitro dynamic digestion behavior of quercetin-loaded liposomes in hydrogels
Lu et al. Development of emulsion gels for the delivery of functional food ingredients: From structure to functionality
Li et al. Control of lipase digestibility of emulsified lipids by encapsulation within calcium alginate beads
Corstens et al. Food-grade micro-encapsulation systems that may induce satiety via delayed lipolysis: A review
Dong et al. Effect of interaction between ovotransferrin fibrils and pectin on properties of oleogel-based Pickering emulsions
Gharibzahedi et al. New trends in the microencapsulation of functional fatty acid‐rich oils using transglutaminase catalyzed crosslinking
Chen et al. Alginate–whey protein granular microspheres as oral delivery vehicles for bioactive compounds
Wu et al. Structural stability and release properties of emulsion-alginate beads under gastrointestinal conditions
CN1893930B (zh) 胃肠道递送系统
Homroy et al. Role of encapsulation on the bioavailability of omega‐3 fatty acids
Bannikova et al. Microencapsulation of fish oil with alginate: In-vitro evaluation and controlled release
Aditya et al. Development and evaluation of lipid nanocarriers for quercetin delivery: A comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE)
JP2017532291A5 (cg-RX-API-DMAC7.html)
Chen et al. Controlling lipid digestion profiles using mixtures of different types of microgel: Alginate beads and carrageenan beads
Mantovani et al. In vitro digestion of oil-in-water emulsions stabilized by whey protein nanofibrils
Tokle et al. Potential biological fate of emulsion-based delivery systems: lipid particles nanolaminated with lactoferrin and β-lactoglobulin coatings
Gu et al. Modulation of lipid digestion profiles using filled egg white protein microgels
US20220280600A2 (en) Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal glp-1 release in a mammal
Yan et al. High internal phase double emulsions stabilized by modified pea protein-alginate complexes: Application for co-encapsulation of riboflavin and β-carotene
Kumar et al. Recent trends in the encapsulation of functional lipids: comprehensive review
Sun et al. Quercetagetin-loaded zein-propylene glycol alginate composite particles induced by calcium ions: Structural comparison between colloidal dispersions and lyophilized powders after in vitro simulated gastraintestinal digestion
Marze Compositional, structural, and kinetic aspects of lipid digestion and bioavailability: In vitro, in vivo, and modeling approaches
Li et al. Designing gastric-stable adsorption layers by whey protein–pectin complexation at the oil–water interface
Alvarez et al. Characterization and in vitro bioaccessability of optimized chia oil-Capsul-sodium alginate microparticles obtained by 3 nozzle spray-drying

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20190705

Address after: Vevey

Applicant after: Societe des Produits Nestle S.A.

Address before: Vevey

Applicant before: Nestle Products Technical Assistance Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210312